Celebrating 40 Years of EACTS | 1986 – 2026

Thoracic Webinar 1: Neoadjuvant immuno-chemotherapy in resectable non-small cell lung cancer: From clinical trials to surgical practice

The management of resectable non-small cell lung cancer (NSCLC) has entered a transformative era with the integration of immunotherapy into the neoadjuvant setting. Combining immunotherapy with chemotherapy prior to surgery has shown promising results, with multiple landmark trials—including CheckMate-816, KEYNOTE-671, AEGEAN, and Neotorch—demonstrating improved pathological response rates and survival outcomes. These findings are rapidly shaping international guidelines and redefining standards of care.
  • 22 Jan 2026
  • Online
Thoracic Disease All Skills Levels

Event Information

  • Date/Duration

    22 January 2026
    18:00 – 20:00 CET Central European Time (2 Hours)

  • Course Director

    M Casiraghi, Milan
    Pulmonary Surgical Oncology Task Force Chair

  • Course Format

    Virtual meeting
    Interactive lectures and videos

  • Target Audience

    Skills Level 1, 2 & 3 – This webinar is aimed at all Skills Levels

  • Course Fee

    Members: Free
    Non-Members: €45

    EACTS Academy terms and conditions.

Course registration

This webinar will explore the biological rationale for this treatment approach, the practical considerations for patient selection, and the critical role of multidisciplinary collaboration in delivering optimal care. Participants will gain insights into staging strategies, biomarker-driven decisions, and coordination across oncology, thoracic surgery, pulmonology, and radiology.

In addition, the faculty will address real-world challenges such as managing treatment-related toxicities, optimising surgical timing, and assessing pathological responses, while also highlighting future directions for clinical research.

Designed for participants at all levels of training and experience, the session will equip attendees with a clear understanding of how to translate emerging trial data into surgical practice and patient-centred outcomes.

Course Programme

18:00Welcome and introductions
M Casirahi, Milan
18:05Integrating molecular profiling into neoadjuvant therapy decisions in NSCLC: present and future
18:25From Clinical Trials to Clinical Practice: Neoadjuvant immuno-chemotherapy in resectable NSCLC
18:40Pulmonary Resections after Chemo-Immunotherapy: is still minimally invasive approach feasible?
18:55Salvage surgery after IO
19:10Ready for prime time – resecting N3 NSCLC?
19:25Clinical case presentation – resident section
19:40Panel discussion and Q&A
20:00Close
Programme and faculty subject to change

Faculty